NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) FCF Margin (2020)

Updated

NovaBridge Biosciences (NBP) posted FCF Margin of -11528.64% for FY2023, down 8197.05 percentage points from -3331.59% in FY2022.

Analysis

NovaBridge Biosciences (NBP) FCF Margin (2020) Analysis & Trends

Since FY2017, NovaBridge Biosciences has reported FCF Margin for 7 years.

  • Annual FCF Margin has declined for three consecutive years, with a five-year change of -10979.91 percentage points (FY2018 to FY2023).
  • The FY2023 figure stands as the lowest annual FCF Margin in data going back to FY2017.
  • Business Quant data shows NBP's FCF Margin at -3331.59% in FY2022 (-2192.11 pp), -1139.48% in FY2021 (-1167.07 pp), 27.59% in FY2020 (+2961.82 pp) and -2934.23% in FY2019 (-2385.50 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.03%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 41.97%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.51%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 52.85%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.25%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 57.81%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 28.96%
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 66.09%
API Access

NovaBridge Biosciences FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NBP&period=max&api_key=YOUR_API_KEY